Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.15 (
pectinase
)
2,440
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The callus culture of duckweed cultivated on medium containing different concentrations of beta-galactosidase was shown to produce the following polysaccharides: pectin lemnan LMC, intracellular AG1, and extracellular
AG2
arabinogalactans. The samples of lemnan with 46% galactose residue reduction and 9-46% increased galacturonic acid residue content were obtained at beta-galactosidase concentrations of 10(-3)-10(-1)mg/mL. The most substantial alterations in the sugar composition of pectin were found to occur in the fraction with a molecular mass of 100-300 kDa. Low concentrations of enzyme failed to influence the sugar composition of intracellular arabinogalactan, whereas high concentrations were shown to decrease the amount of arabinose residues in AG1 and to cause galactan formation. Extracellular galactan was found to be produced on the medium with 10(-1) and 1mg/mL beta-galactosidase whereas extracellular arabinogalactan
AG2
was shown to be biosynthesized without beta-galactosidase or at a beta-galactosidase concentration of 10(-3)mg/mL. Alterations in the sugar composition of polysaccharides were shown to be connected with the increasing activity of alpha-l-arabinofuranosidase and beta-galactosidase, and with the decreasing activity of intracellular
polygalacturonase
.
...
PMID:Action of beta-galactosidase in medium on the Lemna minor (L.) callus polysaccharides. 1983 29